Windtree Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Windtree Therapeutics

17/04/2024 24:17

* Windtree Therapeutics Inc  WINT.OQ  reported a quarterly
adjusted loss of 74 cents​​ per share for the quarter ended in
December.  The lone analyst forecast for the quarter was for a
loss of 94 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Windtree Therapeutics Inc's reported EPS for the quarter
was a
loss of 74 cents​.
    * The company reported a quarterly loss of $5.15 million.
    * Windtree Therapeutics Inc shares had risen by 19.9% this
quarter and lost 41.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $3.00 
This summary was machine generated from LSEG data April 16 at
11:17 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.94          -0.74          Beat
 Sep. 30 2023      -0.63          -0.86          Missed
 Jun. 30 2023      -0.68          -1.64          Missed
 Mar. 31 2023      -0.56          -4.76          Missed